Vivani Medical Inc. Cash Flow Conversion Efficiency
Vivani Medical Inc. cash flow conversion efficiency. Based on the latest financial reports, Vivani Medical Inc. (VANI) has a cash flow conversion efficiency ratio of -0.318x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-6.04 Million) by net assets ($18.97 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Vivani Medical Inc. (2012–2025)
Cash flow conversion efficiency of Vivani Medical Inc. from 2012 to 2025. This chart illustrates how Vivani Medical Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View VANI stock price for real-time trading data and today's change.
Vivani Medical Inc. Cash Flow Conversion Ratio Explained
Vivani Medical Inc. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Vivani Medical Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Vivani Medical Inc. ranked by their cash flow conversion efficiency. Also see how much is Vivani Medical Inc. worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Pasofino Gold Limited
V:VEIN
|
0.426x |
|
Markforged Holding Corp
NYSE:MKFG
|
-0.293x |
|
Hana Pharm Co Ltd
KO:293480
|
0.021x |
|
Wielton S.A.
WAR:WLT
|
-0.086x |
|
Viva Leisure Ltd
AU:VVA
|
0.366x |
|
SINGULAR PEOPLE S EO-1
F:H0U
|
N/A |
|
Bundamedik Tbk PT
JK:BMHS
|
0.083x |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
0.044x |
Annual Cash Flow Conversion Efficiency for Vivani Medical Inc. (2012–2025)
The table below shows the annual cash flow conversion efficiency of Vivani Medical Inc. from 2012 to 2025. Review VANI financial flexibility index to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $15.73 Million | $-24.32 Million | -1.546x | -30.99% |
| 2024-12-31 | $17.61 Million | $-20.79 Million | -1.180x | -3.40% |
| 2023-12-31 | $20.76 Million | $-23.70 Million | -1.142x | -169.22% |
| 2022-12-31 | $44.31 Million | $-18.79 Million | -0.424x | +88.62% |
| 2021-12-31 | $2.46 Million | $-9.19 Million | -3.727x | +4.60% |
| 2020-12-31 | $1.95 Million | $-7.62 Million | -3.907x | -2.88% |
| 2019-12-31 | $7.28 Million | $-27.63 Million | -3.798x | +60.71% |
| 2018-12-31 | $3.08 Million | $-29.81 Million | -9.666x | -218.15% |
| 2017-12-31 | $7.88 Million | $-23.95 Million | -3.038x | -35.12% |
| 2016-12-31 | $11.15 Million | $-25.07 Million | -2.248x | -121.77% |
| 2015-12-31 | $20.27 Million | $-20.55 Million | -1.014x | -105.34% |
| 2014-12-31 | $34.62 Million | $-17.09 Million | -0.494x | -126.13% |
| 2013-12-31 | $-9.22 Million | $-17.43 Million | 1.890x | -62.45% |
| 2012-12-31 | $-3.04 Million | $-15.32 Million | 5.034x | -- |
About Vivani Medical Inc.
Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the t… Read more